Management & Regulatory

Is India Prepared for the Evolving Threat of Bioterrorism?
Management & Regulatory Is India Prepared for the Evolving Threat of Bioterrorism?

Although India maintains a robust network of over 150 viral research laboratories, the architecture is primarily designed for public health rather than forensic attribution. This distinction is becoming increasingly vital as the national security landscape shifts away from large-scale insurgencies

How Will Fortrea’s Latest Acquisition Impact Your Clinical Trials?
Management & Regulatory How Will Fortrea’s Latest Acquisition Impact Your Clinical Trials?

Phase I Pharmacokinetic studies cannot reach their primary endpoints until bioanalytical data is confirmed as valid across the newly integrated organizational framework. The clinical research landscape shifted significantly with the announcement of Fortrea’s acquisition of Worldwide Clinical

Piramal Pharma Highlights ESG Success in New Sustainability Report
Management & Regulatory Piramal Pharma Highlights ESG Success in New Sustainability Report

Piramal Pharma is currently evaluating 38% of its critical suppliers against strict environmental, social, and governance criteria to ensure sustainability throughout the entire value chain. This initiative represents a fundamental shift in how the pharmaceutical industry approaches procurement,

Can a Cyberattack Disrupt Medical Device Manufacturing?
Management & Regulatory Can a Cyberattack Disrupt Medical Device Manufacturing?

While cloud-based applications remained secure, the compromise of on-premises systems halted the ability of a major manufacturer to fulfill essential medical hardware orders. This incident sent immediate shockwaves through the global healthcare sector, highlighting the precarious dependency on

Gland Pharma Hits Regulatory and Financial Milestones
Management & Regulatory Gland Pharma Hits Regulatory and Financial Milestones

Gland Pharma's Visakhapatnam Special Economic Zone Sterile Oncology Facility recently achieved a No Action Indicated status following a USFDA inspection with zero Form 483 observations. This significant regulatory outcome underscores the firm’s commitment to maintaining the highest quality

Can Gene Editing Eliminate PRRS in North American Pork?
Management & Regulatory Can Gene Editing Eliminate PRRS in North American Pork?

The high cost of managing PRRS outbreaks in Mexico has become a primary threat to the business survival of multi-generational family farming operations. Across the North American continent, the swine industry has reached a pivotal moment in its struggle against Porcine Reproductive and Respiratory

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later